263 related articles for article (PubMed ID: 14645580)
1. Signals that dictate nuclear localization of human papillomavirus type 16 oncoprotein E6 in living cells.
Tao M; Kruhlak M; Xia S; Androphy E; Zheng ZM
J Virol; 2003 Dec; 77(24):13232-47. PubMed ID: 14645580
[TBL] [Abstract][Full Text] [Related]
2. GFP/HPV-16E6 fusion protein induces apoptosis in MCF-7 and 293T cells using a transient expression system.
Zhang G; Liu Y; Yu L; Sun L
Oncol Rep; 2012 Nov; 28(5):1673-80. PubMed ID: 22922869
[TBL] [Abstract][Full Text] [Related]
3. Binding of human papillomavirus 16 E6 to p53 and E6AP is impaired by monoclonal antibodies directed against the second zinc-binding domain of E6.
Lagrange M; Charbonnier S; Orfanoudakis G; Robinson P; Zanier K; Masson M; Lutz Y; Trave G; Weiss E; Deryckere F
J Gen Virol; 2005 Apr; 86(Pt 4):1001-1007. PubMed ID: 15784893
[TBL] [Abstract][Full Text] [Related]
4. Nuclear entry of high-risk human papillomavirus type 16 E6 oncoprotein occurs via several pathways.
Le Roux LG; Moroianu J
J Virol; 2003 Feb; 77(4):2330-7. PubMed ID: 12551970
[TBL] [Abstract][Full Text] [Related]
5. Requirement of E6AP and the features of human papillomavirus E6 necessary to support degradation of p53.
Cooper B; Schneider S; Bohl J; Jiang Yh; Beaudet A; Vande Pol S
Virology; 2003 Feb; 306(1):87-99. PubMed ID: 12620801
[TBL] [Abstract][Full Text] [Related]
6. Targetting of the N-terminal domain of the human papillomavirus type 16 E6 oncoprotein with monomeric ScFvs blocks the E6-mediated degradation of cellular p53.
Giovane C; Trave G; Briones A; Lutz Y; Wasylyk B; Weiss E
J Mol Recognit; 1999; 12(2):141-52. PubMed ID: 10398405
[TBL] [Abstract][Full Text] [Related]
7. HPV-16E6 can induce multiple site phosphorylation of p53.
Zhang G; Sun L; Li Z; Si L; Song T; Huang C; Zhang W
Oncol Rep; 2009 Feb; 21(2):371-7. PubMed ID: 19148510
[TBL] [Abstract][Full Text] [Related]
8. The role of exogenous p53 and E6 oncoproteins in in vitro transformation by bovine papillomavirus type 4 (BPV-4): significance of the absence of an E6 ORF in the BPV-4 genome.
Scobie L; Jackson ME; Campo MS
J Gen Virol; 1997 Nov; 78 ( Pt 11)():3001-8. PubMed ID: 9367387
[TBL] [Abstract][Full Text] [Related]
9. Mutational analysis of human papillomavirus type 16 E6 protein: transforming function for human cells and degradation of p53 in vitro.
Nakagawa S; Watanabe S; Yoshikawa H; Taketani Y; Yoshiike K; Kanda T
Virology; 1995 Oct; 212(2):535-42. PubMed ID: 7571423
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of p53 DNA binding by human papillomavirus E6 proteins.
Lechner MS; Laimins LA
J Virol; 1994 Jul; 68(7):4262-73. PubMed ID: 8207801
[TBL] [Abstract][Full Text] [Related]
11. Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation.
Crook T; Tidy JA; Vousden KH
Cell; 1991 Nov; 67(3):547-56. PubMed ID: 1657399
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus type 16 E6 and NFX1-123 mislocalize immune signaling proteins and downregulate immune gene expression in keratinocytes.
Levan J; Vliet-Gregg PA; Robinson KL; Katzenellenbogen RA
PLoS One; 2017; 12(11):e0187514. PubMed ID: 29117186
[TBL] [Abstract][Full Text] [Related]
13. Computational prediction of nuclear localization signals and structural characteristics of 91 types of HPV E6 proteins.
Esmaeili MJ; Mohabatkar H
Asian Pac J Cancer Prev; 2008; 9(4):631-6. PubMed ID: 19256751
[TBL] [Abstract][Full Text] [Related]
14. Transactivation activity of human papillomavirus type 16 E6*I on aldo-keto reductase genes enhances chemoresistance in cervical cancer cells.
Wanichwatanadecha P; Sirisrimangkorn S; Kaewprag J; Ponglikitmongkol M
J Gen Virol; 2012 May; 93(Pt 5):1081-1092. PubMed ID: 22278827
[TBL] [Abstract][Full Text] [Related]
15. Preferential nuclear localization of the human papillomavirus type 16 E6 oncoprotein in cervical carcinoma cells.
Masson M; Hindelang C; Sibler AP; Schwalbach G; Travé G; Weiss E
J Gen Virol; 2003 Aug; 84(Pt 8):2099-2104. PubMed ID: 12867640
[TBL] [Abstract][Full Text] [Related]
16. Telomerase activation by the E6 gene product of human papillomavirus type 16.
Klingelhutz AJ; Foster SA; McDougall JK
Nature; 1996 Mar; 380(6569):79-82. PubMed ID: 8598912
[TBL] [Abstract][Full Text] [Related]
17. p53 degradation activity, expression, and subcellular localization of E6 proteins from 29 human papillomavirus genotypes.
Mesplède T; Gagnon D; Bergeron-Labrecque F; Azar I; Sénéchal H; Coutlée F; Archambault J
J Virol; 2012 Jan; 86(1):94-107. PubMed ID: 22013048
[TBL] [Abstract][Full Text] [Related]
18. Peptide interactions stabilize and restructure human papillomavirus type 16 E6 to interact with p53.
Ansari T; Brimer N; Vande Pol SB
J Virol; 2012 Oct; 86(20):11386-91. PubMed ID: 22896608
[TBL] [Abstract][Full Text] [Related]
19. Differential localization of HPV16 E6 splice products with E6-associated protein.
Vaeteewoottacharn K; Chamutpong S; Ponglikitmongkol M; Angeletti PC
Virol J; 2005 Jun; 2():50. PubMed ID: 15960845
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage.
Kessis TD; Slebos RJ; Nelson WG; Kastan MB; Plunkett BS; Han SM; Lorincz AT; Hedrick L; Cho KR
Proc Natl Acad Sci U S A; 1993 May; 90(9):3988-92. PubMed ID: 8387205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
